| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b56931d402414ac2924944ec413ee2e2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 |
| filingDate |
1998-03-02^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1999-12-21^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_faeed080cce468dc2208ff9fc08c0646
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_601eed2266703208055a8ba3653c0f57 |
| publicationDate |
1999-12-21^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6003516-A |
| titleOfInvention |
Method for treatment of cancer and infectious disease |
| abstract |
Method for treatment of cancer and infectious disease comprises administering a first composition containing interferon-α or analogues thereof, together with a second composition containing at least one substance with H 2 , or 5-HT 1A , receptor agonist activity, for example, histamine or serotonin. The first and second compositions are either mixed in a preparation or furnished in separate doses. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7572436-B1 |
| priorityDate |
1992-06-03^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |